Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 2Neoplasms 2Lung Neoplasms 2Carcinoma, Renal Cell 2Weight Loss 1Triple Negative Breast Neoplasms 1Sleep Apnea Syndromes 1Sezary Syndrome 1Sarcoma 1Overweight 1Obesity, Morbid 1Obesity 1Non-Muscle Invasive Bladder Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Hypertension 1Hyperlipidemias 1Hemangioma 1Gastroesophageal Reflux 1Eczema 1Digestive System Diseases 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Dermatitis, Atopic 1Collagen Diseases 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 60palbociclib 37Trastuzumab 31Letrozole 26Immunohistochemistry 26Drug Therapy 24Anastrozole 24Radiotherapy 21Gene Expression Profiling 20Amplified Fragment Length Polymorphism Analysis 20Mastectomy, Segmental 19Biopsy 19Tamoxifen 18exemestane 17Interviews as Topic 17ribociclib 16Mastectomy 16Fulvestrant 16Paclitaxel 15Magnetic Resonance Spectroscopy 15Psychiatric Rehabilitation 14High-Energy Shock Waves 14Polymerase Chain Reaction 13Observation 13Microarray Analysis 13Capecitabine 13trastuzumab deruxtecan 12Neoadjuvant Therapy 12Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Neoplasms × Urine Specimen Collection × Clear all
NCT00235235 2015-12-09

A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

Hoosier Cancer Research Network

Terminated
80 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡